GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3326 - 3350** of **4050** in total

« First

‹ Prev

…

130

131

132

133

134

135

136

137

138

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgA	Patient 2	3	mild	G84224TW	553
IgM	Patient 2	24	mild	G82204SH	553
IgA	Patient 4	12	mild	G78074HX	553
IgM	Patient 4	12	mild	G78074HX	554
IgA	Patient 4	12	mild	G49916XD	555
IgA	Patient 4	12	mild	G84224TW	555
IgA	Patient 3	4	mild	G91537AT	556
IgA	Patient 2	3	mild	G10789DJ	557
IgA	Patient 3	11	mild	G77974XY	557
IgA	Patient 2	3	mild	G72424VO	559
IgA	Patient 1	10	moderate	G15407YE	560
IgA	Patient 3	-180	mild	G91237TK	560
IgM	Patient 2	15	mild	G51175PR	561
IgA	Patient 2	3	mild	G89993FE	561
IgM	Patient 2	3	mild	G54064FW	564
IgA	Patient 1	22	moderate	G15407YE	565
IgA	Patient 2	24	mild	G25407RZ	566
IgA	Patient 4	12	mild	G36374CE	567
IgA	Patient 2	3	mild	G19118WX	569
IgA	Patient 3	11	mild	G84224TW	569
IgA	Patient 3	4	mild	G77974XY	569
IgM	Patient 1	22	moderate	G80587NA	570
IgM	Patient 2	3	mild	G69912LP	570
IgG	Patient 3	11	mild	G15209MJ	570
IgG	Patient 3	4	mild	G51175PR	572